Touted as a painless alternative to Ozempic and other GLP-1 injections, it promises fast fat burning, appetite suppression, and blood glucose stabilization with a tiny wearable patch
Notably, individuals in the second tertile of Pattern 1 exhibited a significantly decreased risk of T2DM (Hazard Ratio (HR) tertile 2vs1=0.75, 95% Confidence Interval (CI)=0.62-0.90), while those in the highest tertiles of Patterns 3 (HR tertile 3vs1=1.24, 95% CI=1.01-1.53) and 4 (HR tertile 3vs1=2.60, 95% CI=2.14-3.17) demonstrated elevated T2DM risk
How long should I take supplements while on GLP-1 medications
It has no toxic side effects on the human body
Retatrutide needs additional TRIUMPH trial results throughout 2026 before submitting for FDA approval in late 2026 or early 2027, with approval expected in late 2027 and launch in early 2028